News: Berman Tabacco In The News

Insights
Delivered

  • Kathy Becker Named BASF Paralegal of the Year
    December 13th, 2017

    Berman Tabacco is delighted to announce the Bar Association of San Francisco named Senior Paralegal Kathy Becker Paralegal of the Year.

  • Orenstein Promoted To Partner
    December 13th, 2017

    Berman Tabacco is pleased to announce that Nathaniel Orenstein has been promoted to the position of partner. The promotion recognizes the important contributions Nathaniel has made to the firm’s success in prosecuting complex securities and antitrust cases.

  • Patrick Egan and Steven Groopman Present On Pharmacy Benefit Managers Litigation
    October 6th, 2017

    Patrick Egan and Steven Groopman, attorneys in the Boston office, recently spoke before the Coalition of State Rheumatology Organizations about lawsuits targeting Pharmacy Benefit Managers.

  • Joseph J. Tabacco, Jr. Featured in Angeion Group Leading Litigator Series
    October 5th, 2017

    San Francisco founding partner, Joseph J. Tabacco, Jr., was recently interviewed by the Angeion Group–a nationally recognized settlement administration company–for its Leading Litigator video series.

  • Todd Seaver Participates in Antitrust Panel
    October 4th, 2017

    Todd Seaver, a partner in the San Francisco office, spoke as part of an expert panel of global antitrust practitioners in a live webinar on Thursday, September 28th titled Recent Developments in Antitrust and Competition Law.

  • Introducing . . . Berman Tabacco
    September 13th, 2017

    As most of you know by now, last month we changed our name to Berman Tabacco, adding San Francisco partner Joseph Tabacco back onto our masthead. We also bid farewell to our longtime partner, Glen DeValerio, who has moved on to open a firm with his daughter, Daryl.

  • Berman Tabacco Partners Recognized by Best Lawyers
    September 12th, 2017

    Best Lawyers© has recognized San Francisco partners Joseph J. Tabacco, Jr. and Christopher T. Heffelfinger in the area of Litigation – Antitrust in its 24th Edition.

  • Berman DeValerio’s Tenacity Results in Post-Trial Judgment for Plaintiff Class
    August 3rd, 2017

    After six years of hard-fought litigation, including a nine-day trial, Berman DeValerio secured a $3 million disgorgement award against the former CEO and controlling shareholder of PHC, Inc., Bruce A. Shear. The case began in 2011, when PHC agreed to be acquired by Acadia Healthcare, Inc. The plaintiffs alleged that Shear used his position as PHC’s controlling shareholder to wrongfully obtain benefits for himself at the expense of PHC’s other shareholders. Berman DeValerio aggressively pursued the action on behalf of PHC’s aggrieved minority shareholders, overcoming challenging court opinions as well as two trips to the First Circuit Court of Appeals.

  • Northern California Super Lawyers Recognizes Berman DeValerio Attorneys
    July 13th, 2017

    Eight lawyers from Berman Tabacco‘s San Francisco office have been recognized by the Northern California Super Lawyers magazine, published by Thomson Reuters.

  • California Daily Journal Recognizes Tabacco as a Top California Plaintiff’s Lawyer
    July 10th, 2017

    Joseph J. Tabacco, Jr. was recently recognized as a top plaintiff’s lawyer in California. The California Daily Journal recognized Joe for his litigation against the credit rating agencies on behalf of CalPERS, which resulted in settlements totaling $255 million.

  • EpiPen Purchasers Accuse Pharmacy Benefit Managers of ERISA Violations in Class Action Lawsuit
    June 5th, 2017

    A group of EpiPen purchasers have sued their pharmacy benefit managers, known as PBMs, in federal court in Minneapolis. In a lawsuit filed by Berman DeValerio, the EpiPen purchasers claim the PBMs–Express Scripts, CVS Health, and Prime Therapeutics–bear responsibility for the massive increase in the amounts EpiPen purchasers paid out-of-pocket for EpiPen. A copy of the Complaint is available here. The EpiPen purchasers allege that instead of pushing for lower prices from Mylan, the drug company that markets and sells EpiPen, the PBMs demanded rebates from Mylan–and kept a significant amount of those rebates for themselves.

  • Berman DeValerio and Its Attorneys Recognized as Litigation Leaders By Chambers and The Legal 500
    June 1st, 2017

    Berman DeValerio and several of its partners have been recognized as leaders in their areas of practice by some of the legal industry’s leading publications.

  • Legal Food Frenzy Raises Money to Provide 225,000 Meals, With Berman DeValerio Topping Its Field
    June 1st, 2017

    Berman DeValerio raised enough funds to provide 15,000 meals for the Greater Boston Food Bank as part of the two-week Legal Food Frenzy. That is more than any other firm of its size, making it the winner of the charitable challenge in the “medium firm” category.

  • Lavallee and Saif Publish Article on Non-GAAP Accounting
    December 12th, 2016

    Berman DeValerio partner Nicole Lavallee and associate Justin Saif recently published an article in the Fall 2016 issue of the magazine of the California State Association of County Retirement Systems.

  • Berman DeValerio Volunteer Day at Raphael House Family Shelter
    December 12th, 2016

    On Friday, December 2nd, Berman DeValerio’s San Francisco office volunteered at Raphael House family shelter. Raphael House is a privately funded, community-supported organization, which provides homeless and low-income families in the San Francisco Bay Area personalized family-centered solutions, including transitional housing along with mental health counseling, career services, and educational workshops, children’s programs and tutoring, to help at-risk families achieve stable housing and financial independence while strengthening family bonds and personal dignity.

  • Berman DeValerio’s Volunteer Day At the Greater Boston Food Bank A Great Success
    November 7th, 2016

  • Benchmark Litigation 2017 ranks “Highly Recommended” Berman DeValerio as a Top Ten Plaintiffs’ Firm
    October 5th, 2016

    Benchmark Litigation, a publication of U.K.-based Euromoney Institutional Investor plc, has published its 2017 10th Anniversary Edition profiling U.S. law firms. Berman DeValerio is ranked as “Highly Recommended 2017” – the sixth time the firm has received such ranking from Benchmark Litigation.

  • Berman DeValerio Top Fundraising Team for JDC Walk/Bike-A-Thon
    August 19th, 2016

    Berman DeValerio’s team of over 15 walkers and bikers participated in the Justice & Diversity Center’s Walk/Bike-A-Thon fundraiser on July 30, 2016. The Berman DeValerio team was recognized as Top Fundraising Team for this event that raised nearly $20,000 to support The Justice & Diversity Center (“JDC”).

  • Recent Appellate Victory Paves the Way to Trial in California Canadian Car Antitrust Action
    July 27th, 2016

  • Berman DeValerio Attorneys’ Op-Ed Published In The New York Times
    May 13th, 2016

    Boston Managing Partner Kathleen M. Donovan-Maher and Associate Steven L. Groopman co-authored an Op-Ed entitled “Why Dark Money Is Bad Business,” which ran in The New York Times on May 10, 2016. The Op-Ed addresses the recent debate surrounding a proposed SEC rule that would mandate disclosure of corporate political spending.